What kind of opportunities medical students have if they don’t want a traditional medical career? Why is it important to think about medical training as a platform, rather than a predetermined path? In this episode, we answer all of these questions and more, with our guest, Olivia Cavlan MD.
Olivia is Chief Corporate Development and Strategy Officer at Alchemab Therapeutics Ltd, a biotech company developing novel products for patients with hard-to-treat diseases by harnessing the power of naturally protective antibodies.
Olivia holds an MD in Medicine and a BSc in Pharmacology from Bristol University where she graduated with the top First Class Honors.
What are the limitations and challenges of pursuing a career outside the traditional career path? How can physicians broaden their conception of what impact...
What are the biggest barriers to digital therapeutics, and how will the field evolve down the line? How can we make MDs excited about...
How can MDs interested in investing and entrepreneurship break into a very network-driven industry? How can being a doctor in that world helps you ...